Role of ERK activation in growth and erythroid differentiation of K562 cells

Experimental Cell Research

Volumn 264, Issue 2, 2001, Pages 193-200

  Woessmann, Wilhelm ^a,b   Mivechi, Nahid F ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

ERK; Erythroid differentiation; K562; MAPK; Proliferation

Indexed keywords

BCR ABL PROTEIN; HEMIN; HEMOGLOBIN F; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN K 562; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROID CELL; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0035298060     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.5124     Document Type: Article

References (58)

1. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
2. The MAPK signaling cascade
3. Mitogen-activated protein kinase cascades and regulation of gene expression
4. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
5. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling
6. B-Rafinhibits programmed cell death downstream of cytochrom c release from mitochondria by activating the MEK/Erk pathway
7. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation
8. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis
9. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation
10. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway
11. Signal transduction by wild-type and leukemogenic Abl proteins
12. Induction of apoptosis by a dominant negative H-RAS mutant (116Y) in K562 cells
13. Expression of constitutively active Raf-1 in the mitochondria restores anti-apoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant
14. c-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis
15. The proto-oncogene product p210CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BR/VABL to the phosphatidylinositol-3′kinase pathway
16. The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: Roles for phosphatidylinositol 3-kinase and Raf
17. The Bcr-Abl leukemia oncogene activates jun kinase and requires jun for transformation
18. The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells
19. Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR - ABL tyrosine kinase, CGP 57148
20. Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells
21. The inhibition of ERK/MAPK not the activation of JNK/SAPK is primarily required to induce apoptosis in chronic myelogenous leukemic K562 cells
22. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells
23. Induction of neurite outgrowth by MAP kinase in PC12 cells
24. The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte
25. Regulation of heregulin beta1-induced differentiation in a human breast carcinoma cell line by the extracellular-regulated kinase (ERK) pathway
26. Constitutively active mutant of the mitogen-activated protein kinase kinase MEK1 induces epithelial dedifferentiation and growth inhibition in Madin-Darby canine kidney-C7 cells
27. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest
28. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation
29. Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells
30. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells
31. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: Modulation of megakaryocytic differentiation of K562 cells
32. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase
33. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration
34. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adapter protein
35. Mutant forms of growth factor-binding protein-2 revers BCR-ABL-induced transformation
36. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, in inhibitor of tyrosine kinase activity
37. Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate
38. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins
39. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
40. Sodium butyrate induces tyrosine phosphorylation and activation of MAP kinase (ERK-1) in human K562 cells
41. Butyrat-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways
42. Hemin-induced acceleration of hemoglobin production in immature cultured erythroid cells: Preferrential enhancement of fetal hemoglobin
43. Embryonic erythroid differentiation in the human leukemia cell line K562
44. Selective expression of heat shock genes during differentiation of human myeloid leukemic cells
45. CD23 interacts with a new functional extracytoplasmatic domain involving N-linked oligosaccharides on CD21
46. Deficient heine synthesis as the cause of noninducibility of hemoglobin synthesis in a friend leukemia cell line
47. An essential role for mitogen-activated protein kinases, ERKs, in preventing heat-induced cell death
48. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative
49. Downregulation of Bcr-Abl in K562 cells restores susceptibility to apoptosis: Characterization of the apoptotic death
50. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides
51. Bcr-Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors
52. Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells
53. Bcr-Abl-mediated resistance to apoptosis is independent of PI 3-kinase activity
54. Phosphatidylinositol-3-kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
55. A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells
56. PMA-induced phenotypic changes in K562 cells: MAPK-dependent and - independent events
57. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells
58. Signaling mechanism of PMA-induced differentiation of K562 cells